SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 1st, 2021 • Baudax Bio, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledJune 1st, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 31, 2021, between Baudax Bio, Inc., a Pennsylvania corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns a “Purchaser” and collectively, the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT BAUDAX BIO, INC.Placement Agent Common Stock Purchase Warrant • June 1st, 2021 • Baudax Bio, Inc. • Services-misc health & allied services, nec
Contract Type FiledJune 1st, 2021 Company IndustryTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the later of (a) the six-month anniversary of the Closing Date and (b) the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 31, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Baudax Bio, Inc., a Pennsylvania corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement between the Company and H.C. Wainwright & Co., LLC,
COMMON STOCK PURCHASE WARRANT BAUDAX BIO, INC.Common Stock Purchase Warrant • June 1st, 2021 • Baudax Bio, Inc. • Services-misc health & allied services, nec
Contract Type FiledJune 1st, 2021 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the later of (a) the six-month anniversary of the Closing Date and (b) the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 1, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Baudax Bio, Inc., a Pennsylvania corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).